Comparison of CD4 cell count, viral load, and other markers for the prediction of mortality among HIV-1-infected Kenyan pregnant women
about
Challenges and opportunities for the implementation of virological testing in resource-limited settingsEffects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2Changing predictors of mortality over time from cART start: implications for care.Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?Performance of the integrated management of childhood illness algorithm for diagnosis of HIV-1 infection among African infants.Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-to- child HIV transmissionPredictions of CD4 lymphocytes' count in HIV patients from complete blood count.Predictors of CD4 eligibility for antiretroviral therapy initiation among HIV-infected pregnant women in Lusaka, Zambia.The CD4 Lymphocyte Count is a Better Predictor of Overall Infection Than the Total Lymphocyte Count in ANCA-Associated Vasculitis Under a Corticosteroid and Cyclophosphamide Regimen: A Retrospective Cohort.Mortality and health outcomes in HIV-infected and HIV-uninfected mothers at 18-20 months postpartum in Zomba District, Malawi.Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil.Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy.HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial.High Proportion of Deaths Attributable to HIV Among Postpartum Women in Botswana Despite Widespread Uptake of Antiretroviral Therapy.Maternal mortality among HIV-infected pregnant women in Tanzania.
P2860
Q27026923-862B9774-9448-491A-8C93-2DA4798E5D6FQ28728582-06E7E8F3-8619-4A9A-8494-9808809FDA51Q33564975-4F489829-D15F-41A3-AEA1-F03841695662Q33635328-12F48DC3-E432-4952-8A58-663459A78B40Q33961836-6ACEE486-23C1-44F0-8746-C9424E4E13C7Q34157776-DEE226F4-F56E-4303-BB8B-7713AE09DD91Q34986925-4FAA876A-03B7-4691-8AC6-35179F079D23Q35175456-FABBEC34-7574-42FB-9D23-024CB9EFD704Q36151396-5AAB6C28-0341-4CE8-A826-125A6C038FA0Q36207424-941ED714-BB5E-4A13-A343-38867BADF6D0Q36221392-333499F8-7DDE-4592-94CE-D9F1452B1EDEQ36440576-3AC58FA5-3B7A-4D40-94DE-175666EFBE32Q37238836-04DA4CD4-5ED6-43DF-BEF9-87D383642E1BQ39041259-448D3B03-BC08-456E-ACDD-A5552265813EQ42224617-3A2A10A5-A603-497D-918B-594F8B31F406
P2860
Comparison of CD4 cell count, viral load, and other markers for the prediction of mortality among HIV-1-infected Kenyan pregnant women
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of CD4 cell count, ...... infected Kenyan pregnant women
@en
Comparison of CD4 cell count, ...... nfected Kenyan pregnant women.
@nl
type
label
Comparison of CD4 cell count, ...... infected Kenyan pregnant women
@en
Comparison of CD4 cell count, ...... nfected Kenyan pregnant women.
@nl
prefLabel
Comparison of CD4 cell count, ...... infected Kenyan pregnant women
@en
Comparison of CD4 cell count, ...... nfected Kenyan pregnant women.
@nl
P2093
P2860
P50
P921
P356
P1476
Comparison of CD4 cell count, ...... infected Kenyan pregnant women
@en
P2093
Carey Farquhar
Dorothy A Mbori-Ngacha
Elizabeth R Brown
Grace C John-Stewart
P2860
P304
P356
10.1086/597617
P407
P577
2009-05-01T00:00:00Z